Summary of HR 2767 - BRAIN Act

Overview

The Bolstering Research And Innovation Now Act, commonly referred to as the BRAIN Act, is a legislative proposal aimed at enhancing research and innovation in the field of brain cancer, particularly focusing on glioblastoma and related conditions. The bill was introduced in the House of Representatives on April 9, 2025, and is currently under consideration by the House Committee on Energy and Commerce.

Purpose and Intent

The primary intent of the BRAIN Act is to:
- Foster advancements in brain cancer research.
- Improve patient access to clinical trials and innovative therapies.
- Enhance public awareness regarding brain cancer and its treatment options.

Key Provisions

The BRAIN Act includes several significant provisions designed to support brain cancer research and patient care:

1. Fostering Transparency of Biospecimen Collections:

   • Establishes guidelines to improve the transparency and accessibility of biospecimen collections used in brain cancer research.

2. Glioblastoma Therapeutics Network:

   • Creates a network focused on developing cellular immunotherapy treatments for glioblastoma, including a team science award to promote collaborative research efforts.

3. Public Awareness Campaign:

   • Initiates a national campaign to raise awareness about cancer clinical trials and biomarker testing, aiming to educate patients and healthcare providers.

4. Pilot Programs for Brain Tumor Survivors:

   • Develops pilot programs to monitor and evaluate approaches for the care of brain tumor survivors, addressing their unique health needs.

5. FDA Guidance:

   • Directs the FDA to provide guidance that ensures brain tumor patients have access to clinical trials, facilitating their participation in cutting-edge research.

Affected Parties

The BRAIN Act is expected to impact:
- Patients: Particularly those diagnosed with brain tumors, including glioblastoma, by improving access to innovative treatments and clinical trials.
- Researchers and Healthcare Providers: By fostering collaboration and transparency in research efforts, the bill aims to enhance the overall quality of brain cancer research.
- Public Health: Through awareness campaigns, the bill seeks to inform the general public about brain cancer and available treatment options.

Legislative Process

• Introduced: April 9, 2025
• Current Status: Referred to the House Committee on Energy and Commerce for further consideration.

Sponsors

The BRAIN Act has a diverse group of sponsors, including:
- Primary Sponsor: Brian K. Fitzpatrick
- Cosponsors: Notable cosponsors include Michael Lawler, Young Kim, Eric Sorensen, and Rashida Tlaib, among others, reflecting bipartisan support for the initiative.

Related Legislation

The BRAIN Act has a companion bill, S 1330, which is being considered in the Senate, indicating a coordinated effort to advance brain cancer research at both legislative chambers.

This summary provides an overview of the BRAIN Act, highlighting its purpose, key provisions, and potential impact on brain cancer research and patient care.